Clinical and Genetic Screening for Hypertrophic Cardiomyopathy in Paediatric Relatives: Changing Paradigms in Clinical Practice
Hypertrophic cardiomyopathy (HCM) is an important cause of morbidity and mortality in children. While the aetiology is heterogeneous, most cases are caused by variants in the genes encoding components of the cardiac sarcomere, which are inherited as an autosomal dominant trait. In recent years, ther...
Main Authors: | Claire M. Lawley, Juan Pablo Kaski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/8/2788 |
Similar Items
-
Current and emerging perspectives on pathophysiology, diagnosis, and management of hypertrophic cardiomyopathy
by: Ilias K. Gartzonikas, et al.
Published: (2023-03-01) -
The Role of Cardiovascular Magnetic Resonance Imaging in the Evaluation of Hypertrophic Cardiomyopathy
by: Sanjay Sivalokanathan
Published: (2022-01-01) -
SUDDEN DEATH IN HYPERTROPHIC CARDIOMYOPATHY: SEARCH FOR NEW RISK FACTORS
by: N. S. Krylova, et al.
Published: (2017-02-01) -
Clinical Utility of Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
by: Maron Martin S
Published: (2012-02-01) -
Hypertrophic, Dilated, and Arrhythmogenic Cardiomyopathy: Where Are We?
by: Hamza El Hadi, et al.
Published: (2023-02-01)